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Diarrhoea in the critically ill is 
common, associated with poor 
outcome, and rarely due to 
Clostridium difficile
Nikhil Tirlapur1, Zudin A. Puthucheary2,3,4, Jackie A. Cooper5, Julie Sanders6, Pietro G. Coen7, 
S. Ramani Moonesinghe8, A. Peter Wilson9, Michael G. Mythen10 & Hugh E. Montgomery3,11
Diarrhoea is common in Intensive Care Unit (ICU) patients, with a reported prevalence of 15–38%. Many 
factors may cause diarrhoea, including Clostridium difficile, drugs (e.g. laxatives, antibiotics) and enteral 
feeds. Diarrhoea impacts on patient dignity, increases nursing workload and healthcare costs, and 
exacerbates morbidity through dermal injury, impaired enteral uptake and subsequent fluid imbalance. 
We analysed a cohort of 9331 consecutive patients admitted to a mixed general intensive care unit to 
establish the prevalence of diarrhoea in intensive care unit patients, and its relationship with infective 
aetiology and clinical outcomes. We provide evidence that diarrhoea is common (12.9% (1207/9331) 
prevalence) in critically ill patients, independently associated with increased intensive care unit length 
of stay (mean (standard error) 14.8 (0.26) vs 3.2 (0.09) days, p < 0.001) and mortality (22.0% (265/1207) 
vs 8.7% (705/8124), p < 0.001; adjusted hazard ratio 1.99 (95% CI 1.70–2.32), p < 0.001) compared to 
patients without diarrhoea even after adjusting for potential confounding factors, and infrequently 
caused by infective aetiology (112/1207 (9.2%)) such as Clostridium difficile (97/1048 (9.3%) tested) or 
virological causes (9/172 (5.7%) tested). Our findings suggest non-infective causes of diarrhoea in ICU 
predominate and pathophysiology of diarrhoea in critically ill patients warrants further investigation.
Diarrhoea is defined as having 3 or more loose or liquid stools per day with stool volume greater than 250 ml/
day1. In the intensive care unit (ICU) it may result from a range of infective (e.g. Clostridium difficile or norovi-
rus), pharmaceutical (e.g. laxatives and enemas) or other non-infective causes (e.g. pancreatic insufficiency and 
continuous enteral tube-feeding)1,2. Diarrhoea in the critically ill impacts on patient dignity, increases nursing 
workload and ICU costs, and exacerbates patient morbidity through dermal injury, impaired enteral uptake and 
subsequent fluid and electrolyte imbalance3–5. Diarrhoea represents grade II (of IV) gastrointestinal (GI) injury 
according to recent European Society of Intensive Care Medicine (ESICM) guidelines, indicating that digestion 
and absorption are inadequate to satisfy systemic nutrient and fluid requirements6.
Gastrointestinal symptoms are frequent in the ICU7–9, and appear associated with impaired outcome in the 
critically ill8,10–12. However, few studies have sought to determine the prevalence of diarrhoea in critically ill 
patients, the likelihood of identifying an infectious origin, or the clinical impact of diarrhoea on ICU length of 
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stay (LOS) or mortality. No previous studies have sought association with antecedent laxative use, which has a 
potential aetiological role.
We thus aimed to (i) characterise the prevalence of diarrhoea in ICU in a large consecutive patient cohort, (ii) 
define the proportion in whom an infective agent was identified, (iii) report association with laxative or enema 
use, and (iv) explore the association of diarrhoea with ICU outcome.
Results
Prevalence. Between 01/01/2006 and 31/12/2010, 7697 patients with 9331 admissions meeting the inclu-
sion criteria were admitted to University College Hospital (UCH) ICU (mean age ± standard deviation (SD) 
58.6 ± 17.7 years, 55.0% male, 66.9% from surgical admissions, median (interquartile range (IQR)) Acute 
Physiology and Chronic Health Evaluation (APACHE) II score 16 (11–22)). Diarrhoea affected the patient in 1207 
(12.9%) of these admissions (Fig. 1). The demographics for the study group are shown in Table 1. The relation-
ship between diarrhoea and type of surgery (gastrointestinal vs non-gastrointestinal) is shown in Supplementary 
Table S1. The prevalence of diarrhoea in ICU re-admissions was 23.1% (178/772), compared to 13.3% (85/637) 
in re-admitted patients on their first admission and 11.9% (946/7922) of patients with only one ICU admission.
Figure 1. Flow chart of patient enrolment. 
Admissions with Diarrhoeaa 
(N = 1207)
Admissions with No Diarrhoeaa 
(N = 8124) P-value
Age [mean (standard deviation)] 60.8 (16.5) 58.3 (17.8) < 0.001
Male sex 678 (56.2%) 4457 (54.9%) 0.40
Referring Specialty
 Medical 726 (60.1%) 2358 (29.0%) < 0.001
 Surgical 481 (39.9%) 5766 (71.0%)
APACHE II scoreb  
 [median (interquartile range)] 22 (17–28) 16 (11–21) < 0.001
Reason for Intensive Care Unit admission
 Cardiovascular 109 (9.0%) 487 (6.0%) < 0.001
 Respiratory failure 351 (29.1%) 878 (10.8%) < 0.001
 Haemorrhage 81 (6.7%) 556 (6.8%) 0.85
 Sepsis 200 (16.6%) 455 (5.6%) < 0.001
 Renal failure 67 (5.6%) 138 (1.7%) < 0.001
 Operative intervention 228 (18.9%) 4735 (58.3%) < 0.001
 Neurological 91 (7.5%) 534 (6.6%) 0.20
 Haematological 40 (3.3%) 99 (1.2%) < 0.001
 Liver failure 17 (1.4%) 60 (0.7%) 0.03
 Other 23 (1.9%) 182 (2.2%) 0.53
Table 1. Demographic and baseline characteristics for diarrhoea and non-diarrhoea groups. aData shown 
as N (%) unless stated otherwise. bAcute Physiology and Chronic Health Evaluation (APACHE) II score.
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Infective aetiology. Of the 1207 admissions associated with diarrhoea, 111 (9.2%) had pathological micro-
biological stool samples (‘positive samples’): 6/1149 (0.5%) stool samples sent for microscopy/culture, 97/1048 
(9.3%) samples sent for C. difficile toxin or antigen, and 9/172 (5.2%) samples sent for virological analysis. Positive 
stool cultures were for Salmonella (4), Campylobacter (2) and Candida albicans (1). The single case with Candida 
albicans was not utilised in analysis of infective diarrhoea, as this organism was deemed unrelated to diarrhoea 
pathogenesis. Positive virology samples were all for norovirus (9). All norovirus cases were community or 
hospital-acquired, and none originated from ICU.
Out of 97 positive C. difficile samples, 27 (27.8%) were antigen positive only and 70 (72.2%, involving 67 
patients) were toxin positive (Table 2). C. difficile was thus the most commonly diagnosed infective cause of 
diarrhoea, occurring in 97 admissions, involving 94 individual patients (mean age ± SD 65.1 ± 16.2 years, 60.8% 
male, 53.6% medical admissions, median (IQR) APACHE II score 22 (17–29)). Amongst those affected, 21 were 
post-operative patients, with the most common medical reasons for admission being respiratory failure (28/97) 
or sepsis (21/97).
One patient tested positive for both C. difficile and norovirus during the same ICU admission. The prevalence 
of C. difficile (97/9331) and norovirus (9/9331) was 1.0% and 0.1% respectively. The prevalence of C. difficile 
(23/772) and norovirus (1/772) during re-admissions was 3.0% and 0.1% respectively.
Laxatives, Suppositories and Enemas. Of 9331 ICU patient admissions, 1635 (17.5%) received laxatives 
during their stay. Some 244/1207 (20.2%) admissions with diarrhoea received laxatives ≤ 24 hours prior to its 
onset, while 13/97 (13.4%) admissions with positive C. difficile samples were receiving laxatives within 24 hours 
of their positive C. difficile sample.
Overall, 1219 (13.1%) of ICU admissions received enemas/suppositories. Of the 1207 diarrhoea cases, 137 
(11.4%) received enemas/suppositories ≤ 12 hours prior to its onset.
Clinical outcomes. The median (IQR) ICU LOS was 1.9 (0.9–4.5) days and ICU mortality was 10.4% 
(970/9331). When compared to admissions without diarrhoea, admissions with diarrhoea experienced longer 
ICU LOS (median (IQR) 9.5 (4.6–20.2) vs 1.7 (0.9–3.2) days, p < 0.001) and greater ICU mortality ((22.0% 
(265/1207) vs 8.7% (705/8124), p < 0.001).
Median ICU LOS for patients with C. difficile was 17.4 (8.4–32.3) days. 26 out of 94 (27.6%) patients with 
either C. difficile antigen or toxin positive samples died during their ICU admission. 23 out of 67 (34.3%) patients 
with C. difficile toxin positive samples died during their ICU admission, which was not significantly greater com-
pared with other admissions of patients suffering diarrhoea during their ICU stay after adjusting for APACHE 
II score (odds ratio (OR) 1.41, 95% confidence interval (CI) 0.87–2.30, p = 0.168). No patients required surgical 
colonic resection for C. difficile infection.
We performed multivariate regression analysis to adjust for confounding imbalances between diarrhoea and 
non-diarrhoea groups. Using ordinal logistic regression analysis, the unadjusted odds of a longer ICU stay in 
patients suffering diarrhoea was 16.3 (95% CI 14.39–18.46, p < 0.001). Increasing APACHE II score was asso-
ciated with increased ICU stay, while patients admitted to ICU due to operative intervention had significantly 
shorter ICU LOS compared to all other causes, except for haemorrhage (Table 3). Adjusting for age, referring 
specialty, APACHE II and reason for ICU admission (including operative intervention to adjust for post-surgical 
patients with expected short ICU stays), ICU LOS was significantly greater in patients suffering diarrhoea than 
those without (OR 9.48, 95% CI 8.32–10.81, p < 0.001), the adjusted mean ICU stay estimated to be 11.6 days 
greater (mean (standard error) 14.8 (0.26) vs 3.2 (0.09) days, p < 0.001).
We assessed the relationship between ICU LOS and time from ICU admission to diagnosis of diarrhoea using 
a Cox proportional hazard model with diarrhoea as a time-dependent covariate (Fig. 2). The proportional haz-
ards assumption did not hold as hazard curves crossed at 13 days. Analysis before and after this cut point showed 
admissions of patients suffering diarrhoea early in their ICU stay (within 13 days) were less likely to be dis-
charged than admissions not suffering diarrhoea (hazard ratio 0.91, 95% CI 0.83–0.99, p = 0.03), but admissions 
of patients suffering diarrhoea later in their ICU stay (after 13 days) were more likely to be discharged from ICU 
than those not suffering diarrhoea (hazard ratio 3.15, 95% CI 2.65–3.74, p < 0.001).
The relationship between diarrhoea and mortality was analysed by modelling data as time to death using a 
Cox proportional hazard model with diarrhoea as a time-dependent covariate (Fig. 3). The hazard ratio of mor-
tality for admission with vs without diarrhoea was 1.99 (95% CI 1.70–2.32, p < 0.001). Higher ICU mortality was 
Admissions Suffering Diarrhoea During Their 
ICU Stay (N = 1207) Number (%) ICU Mortality (%)
Clostridium difficile positive 97 (8.0) 26 (26.8)
 Glutamate dehydrogenase antigen positive only 27 (2.2) 3 (11.1)
 Toxin positive 70 (5.8) 23 (32.9)
Clostridium difficile negative 1112 (92.1) 240 (21.6)
 Preceding laxative and/or enema use 305 (25.3) 71 (23.3)
 Negative stool sample 793 (65.7) 169 (21.3)
 Positive stool sample 14 (1.2) 0 (0)
Table 2. Admissions of patients suffering diarrhoea comparing admissions with stool samples positive vs 
negative for Clostridium difficile.
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observed for older patients, those with a medical referral, and increasing APACHE II score. Patients admitted to 
ICU due to operative intervention had significantly lower ICU mortality compared to all other causes (Table 4).
Discussion
Our study is the largest yet to describe the prevalence of diarrhoea in the ICU. We found diarrhoea to be com-
mon (12.9% prevalence) and to be associated with increased crude ICU LOS and mortality, both persisting after 
adjustment for severity of illness and other potential confounding factors. A low yield (9.2%) for microbiologi-
cal/virological stool investigations and low prevalence of Clostridium difficile (1.0%) and norovirus (0.1%) sug-
gest non-infective causes may be playing a significant aetiological role. In this regard, over one-fifth of patients 
received laxatives (20.2%) and/or enemas/suppositories (11.4%) prior to diarrhoea onset.
The high prevalence of diarrhoea (12.9%) in our study of 9331 consecutive ICU admissions is consistent with 
established literature, which reports a prevalence of 9.7–41%3,7,13,14. Indeed, given that our diagnosis of diarrhoea 
Co-variatesa
Odds Ratio (95% Confidence Interval) 
for Increased Intensive Care Unit Stay P-value
Age (per 10 year increase) 0.99 (0.96–1.01) 0.20
Surgical: Medical 1.08 (0.95–1.21) 0.23
Quintile of APACHE IIb
 1 1.00 < 0.001
 2 1.95 (1.74–2.19)
 3 2.87 (2.55–3.23)
 4 4.30 (3.81–4.86)
 5 6.56 (5.74–7.49)
Reason for Intensive Care Unit admission
 Operative intervention 1.00
 Cardiovascular 1.81 (1.51–2.17) < 0.001
 Respiratory failure 3.27 (2.83–3.78) < 0.001
 Haemorrhage 1.13 (0.96–1.32) 0.14
 Sepsis 2.28 (1.92–2.70) < 0.001
 Renal failure 1.93 (1.48–2.52) < 0.001
 Neurological 1.34 (1.11–1.61) 0.002
 Haematological 1.66 (1.19–2.31) 0.003
 Liver failure 3.73 (2.50–5.58) < 0.001
 Other 1.66 (1.29–2.14) < 0.001
Diarrhoea vs. Non-Diarrhoea 9.48 (8.32–10.81) < 0.001
Table 3. Ordinal logistic regression analysis for length of intensive care unit stay for admissions with vs 
without diarrhoea. aOrdinal logistic regression analysis: dependent variable is length of ICU stay in days. 
bAcute Physiology and Chronic Health Evaluation II score.
Figure 2. Kaplan-Meier estimate of time to discharge for admissions of patients suffering diarrhoea during 
their intensive care unit stay vs admissions not suffering diarrhoea using a Cox proportional hazards model 
with diarrhoea as a time dependent co-variate. 
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depended upon a stool sample being sent, we may have underestimated its prevalence, especially of milder cases. 
The baseline demographics for our patient cohort suffering diarrhoea (median [IQR] 62.8 years [49.7–73.2], 
56.2% male) were similar to a 10-year retrospective analysis of 5260 ICU patients from 3 ICUs in France (median 
[IQR] 67 years [56–76], 61.5% male)14.
Our low yield (9.2%) of positive stool samples and low yield (9.3%) of positive C. difficile samples compares 
with a yield of 13.5% (69/512) positive C. difficile samples from the French ICU patient cohort14, which only ana-
lysed stool samples 72 hours after ICU admission exclusively looking for C. difficile infection. We looked at the 
index sample sent from patients at any time from ICU admission. Taken together, these findings suggest the role 
of non-infective causes of diarrhoea warrants further study. While the introduction of C. difficile antigen testing 
for the last 19 months of the study might have increased the total number of C. difficile positive cases, the total 
number (n = 97) and percentage (9.3%) of C. difficile positive cases over the study period remains small and in 
keeping with our overall conclusions. If the C. difficile infection rate was based on C. difficile toxin-positive cases 
only (n = 70), the prevalence of C. difficile infection in our cohort is even lower (0.8%).
Figure 3. Kaplan-Meier survival curves for admissions of patients suffering diarrhoea during their 
intensive care unit stay vs admissions not suffering diarrhoea using a Cox proportional hazards model with 
diarrhoea as a time dependent co-variate. 
Co-variatesa
Odds Ratio (95% 
CI) for mortality P-value
Age (per 10 year increase) 1.18 (1.13–1.23) < 0.001
Surgical: Medical 0.52 (0.43–0.62) < 0.001
Quintile of APACHE-IIb
 1 1.00
 2 0.32 (0.23–0.46)
 3 0.46 (0.35–0.61) < 0.001
 4 0.72 (0.58–0.90)
 5 1.27 (1.04–1.56)
Reason for ICU admission
 Operative intervention 1.00
 Cardiovascular 2.99 (2.26–3.95) < 0.001
 Respiratory failure 2.01 (1.55–2.59) < 0.001
 Haemorrhage 1.77 (1.28–1.44) < 0.001
 Sepsis 1.75 (1.31–2.34) < 0.001
 Renal failure 1.49 (1.02–2.20) 0.04
 Neurological 1.96 (1.43–2.69) < 0.001
 Haematological 1.98 (1.23–3.21) 0.005
 Liver failure 3.23 (1.91–5.47) < 0.001
 Other 2.12 (1.32–3.42) 0.002
Diarrhoea vs. Non-Diarrhoea 1.99 (1.70–2.32) < 0.001
Table 4. Analysis for intensive care unit (ICU) mortality for admissions of patients suffering vs not 
suffering diarrhoea during their ICU stay. aCox proportional hazard model with diarrhoea as a time 
dependent co-variate. bAcute Physiology and Chronic Health Evaluation II score.
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Our study is the largest to look at laxative and enema/suppository use prior to episodes of diarrhoea. Over 20% 
of patients suffering diarrhoea had received laxatives or enemas/suppositories immediately prior to diarrhoea 
onset, suggesting a possible aetiological role. There is sparse literature regarding the non-infective aetiology of 
diarrhoea in critically ill patients. A 1-year prospective study of ICU patients found a 41% incidence of diarrhoea 
with increased incidence in patients receiving nasogastric feeding and no increased incidence in those receiving 
antibiotics3. A multi-centre observational study in 37 Spanish ICUs on 400 patients admitted to ICU who received 
enteral nutrition found 14.7% of patients suffered diarrhoea7, while a 3-month prospective study of 39 patients 
receiving enteral nutrition found patients suffered diarrhoea on 38% of feeding days13. A 1-month prospective 
study of ICU patients in Spain found 21.6% of 162 patients suffering diarrhoea received laxatives during their 
ICU admission15. A 2-month prospective study of 278 ICU patients in Switzerland, observing risk factors other 
than laxatives and C. difficile infection in the first 14 days of ICU admission, found enteral nutrition > 60% of 
energy target, use of antibiotics and anti-fungal drugs as independent risk factors for developing diarrhoea in 
ICU16. There was no significant relationship between type of surgery (gastrointestinal vs non-gastrointestinal) 
and admissions of patients suffering diarrhoea in both the total study population (p = 0.96) and the subgroup of 
critical care admissions due to operative intervention (p = 0.68, Supplementary Table S1).
Patients suffering diarrhoea had significantly longer ICU LOS and ICU mortality, even after adjusting for 
confounding factors. Diarrhoea remained independently associated with an 11.6 day increase in ICU LOS 
(p < 0.001). Few others have sought such association, although Clostridium difficile infection has been reported 
to be associated with an estimated (non-statistically significant) 6.3 day increase in ICU LOS14.
The association of diarrhoea with ICU LOS could be explained in one of two ways. Firstly, those staying longer 
might be at greater risk of developing diarrhoea. Alternatively, the presence of diarrhoea might itself be causally 
associated with increased LOS. However, our analysis revealed that patients suffering diarrhoea early in their 
ICU stay (within 13 days) were less likely to be discharged than patients not suffering diarrhoea (hazard ratio 
0.91, p = 0.03), but patients suffering diarrhoea later in their ICU stay (after 13 days) were more likely to be dis-
charged from ICU than those not suffering diarrhoea (hazard ratio 3.15, p < 0.001). This suggests time from ICU 
admission to developing diarrhoea was not a confounding factor. In our institution, persistent diarrhoea is not 
a common reason for keeping patients in the ICU if the patient is euvolaemic, haemodynamically stable and not 
requiring aggressive ongoing fluid replacement. Delayed discharge through lack of single room accommodation 
on the general wards is comparable to other United Kingdom ICUs, with only 25% of general ward beds at UCH 
having single room accommodation.
The crude mortality rate of patients with diarrhoea was 22%, which is similar to findings from studies observ-
ing outcomes from Clostridium difficile infection in ICU patients14,17–20. The adjusted mortality risk for patients 
suffering diarrhoea in ICU was 2-fold greater (hazard ratio 1.99, p < 0.001) than patients not suffering diarrhoea 
at any time point during ICU admission.
We cannot ascribe the increased ICU LOS and ICU mortality with which diarrhoea was associated to this 
condition itself. However, this association remained after adjusting for confounding factors. Further, there is 
good rationale for believing that diarrhoea could have such a direct impact. Diarrhoea is shown to impair nutrient 
intake by the enteral route in ICU patients, exposing patients to undernutrition through enteral feeding intol-
erance8,12,21. Reduced enteral intake and resulting malnutrition is shown to be an independent risk factor for 
in-hospital mortality22. Further, it causes dermal injury, impaired enteral uptake and subsequent fluid and elec-
trolyte imbalance3–6.
There are several limitations to our retrospective study. Firstly, the prevalence of diarrhoea may have been 
higher than reported, if diarrhoea occurred but no stool sample was sent. However, with protocols in place, we 
think such cases are likely to be few. We may have underestimated the number of infective cases given that we 
only studied the results from the index stool sample, and sequential samples may have yielded positive results. 
We did not explore all causes of diarrhoea such as the influence of enteral feeding and antibiotics for which 
data were not fully available from computerised records. Other potential confounding factors, such as patient 
co-morbidities, levels of organ support and incidence of nosocomial infections, could not be accounted for which 
may have caused an estimation bias with our results. We recommend a full prospective study to observe the influ-
ence of factors such as type of feeding, co-existing infection, and presence of diseases altering stool frequency on 
the development and duration of diarrhoea in critically ill patients.
Diarrhoea increases ICU workload and healthcare costs, causes patient indignity and morbidity, and may be 
associated with increased ICU LOS and mortality. ESICM comment that GI tract changes in critically ill patients 
remain poorly understood, while a lack of markers of GI function has limited progress in exploring GI dysfunc-
tion6. Studies are clearly needed to increase our knowledge of GI tract pathophysiology which predisposes ICU 
patients to changes in bowel function. Increased understanding of changes in bacterial flora, GI tract mucosa 
and GI tract perfusion23 may inspire insights into potential biomarkers and novel therapeutic targets, and enable 
evidence-based guidelines to reduce the clinical and financial burden of diarrhoea on critically ill patients.
Meanwhile, reviewing gastrointestinal function should be a routine part of general housekeeping for inten-
sivists. Early recognition, appropriate investigation and prompt treatment are necessary to reduce the burden of 
diarrhoea on the already fragile ICU patient. Increasing evidence suggests early protocolised and goal-directed 
care can improve organ function and patient outcomes during critical illness6,21,24–26. Once diarrhoea is recog-
nised, clearly defined protocols should be implemented which identify the cause, reduce risk of transmission of 
infectious agents, and treat reversible aetiology. Diarrhoea in the critically ill is likely to be multifactorial. While 
the importance of excluding infective causes cannot be understated, the low positive yield of stool investigations 
in our study suggests non-infective causes should also be identified. Rational stool sample testing should be used 
to balance clinical risk with unnecessary cost. Our findings of over 20% of patients receiving laxatives and/or ene-
mas/suppositories before diarrhoeal episodes suggest a need for rational prescribing during diarrhoeal episodes 
to reduce unnecessary burden on critically ill patients.
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Conclusions
Diarrhoea was common on our ICU with a prevalence of 12.9%. Adjusting for baseline differences, patients suf-
fering diarrhoea experienced increased ICU length of stay and increased ICU mortality compared with patients 
without diarrhoea.
A low yield of stool investigations and low prevalence of Clostridium difficile and norovirus suggest a possible 
pathogenic role for non-infective processes. Several patients received laxatives and enemas before diarrhoeal 
episodes suggesting a need for rational intensivist prescribing.
Further studies are warranted to establish the pathogenesis of gastrointestinal dysfunction in critically ill 
patients, in order to develop evidence-based management plans for reducing the incidence of diarrhoea, and its 
clinical and financial impact.
Methods
Study design and setting. University College Hospital (UCH) is an 846-bed Central London teaching 
hospital with over 120,000 hospital admissions per year. Departmental computerised patient records were ana-
lysed to identify all patients aged > 18 years admitted for level 2 or 3 care to its 35-bed mixed medical/surgical 
adult ICU, in the 60 months between 01/01/2006 and 31/12/2010. During this time, UCH provided surgery for all 
major specialties except cardiothoracic and neurosurgery. In 2009, UCH opened a Post-Anaesthesia Care Unit as 
part of its critical care facilities, which saw an increase in post-surgical ICU admissions.
Our study was reviewed by the University College London Joint Research Office who deemed this study a 
service evaluation which did not require formal ethics approval. Consent was not required as our study involved 
retrospective analysis of anonymous, routinely collected group data from University College Hospital.
Data collection. A procedure for sending stool samples is clearly defined for UCH ICU, with samples being 
sent for microbiological/virological assessment in the case of loose stools, according to the Bristol Stool Chart27. 
Patients with such samples sent during their ICU admission were deemed to have suffered diarrhoea.
The index stool samples for each patient admission were analysed for stool microscopy and culture, 
Clostridium difficile toxin A and B using an immunoassay enzyme28, Clostridium difficile glutamate dehydroge-
nase antigen, and virology. The choice of gastrointestinal virus selected for analysis was guided by clinical his-
tory (e.g. vomiting and diarrhoea, community or outbreak acquisition). A standard screening panel (since 2000) 
includes Norovirus 1 and 2, Rotavirus and Adenovirus. Clostridium difficile antigen testing was introduced 
during the study period at UCH in June 2009, and added to our Clostridium difficile toxin testing. Presence of 
Clostridium difficile antigen indicates carriage of a potentially toxin-producing organism which may develop 
into disease. Presence of Clostridium difficile toxin is most likely to be associated with disease. Both Clostridium 
difficile toxin-positive and toxin-negative/antigen-positive samples were classified as positive infectious sam-
ples. Stool sample results were compiled and analysed with data collected from computerised patient records.
Demographic data, including age, sex, admissions category (medical or surgical), Acute Physiology and 
Chronic Health Evaluation (APACHE) II score29 and reason for ICU admission, were collected. Laxatives 
(Lactulose, Senna, Polyethylene Glycol, Docusate Sodium, Ispaghula Husk, Sodium Picosulfate with Magnesium 
Citrate), suppositories (Glycerol) and enemas (Phosphates) received during patient ICU admission were also 
recorded. Outcome variables recorded for all patient admissions were ICU LOS and ICU mortality.
Statistical analysis. Patient data were extracted from the hospital database, compiled with stool sample 
results, and analysed using Microsoft Access 2010 (Microsoft, Redmond, Washington, USA) and Stata Version 
13 (StataCorp, Texas, USA). Data were compared between patients suffering diarrhoea during their admission 
and patients not suffering diarrhoea during their admission. Continuous variables were analysed using the 
Mann-Whitney U test or Student’s t-test and categorical data were analysed using Fisher’s exact test. Multivariate 
models were used to adjust for baseline characteristics (age, admission category, APACHE II, operative inter-
vention and other variables that were significantly different between the two groups) when examining the effect 
of diarrhoea on ICU LOS and mortality. For ICU LOS a multiple regression model was used to estimate the 
difference in LOS. As LOS was not normally-distributed, we also used an ordinal logistic regression model to 
obtain an odds ratio for an increased LOS. Cox proportional hazard models were used to assess the relationship 
between ICU LOS from the time of diarrhoea diagnosis, and to assess mortality risk during ICU admission in 
admissions with and without diarrhoea. Diarrhoea was fitted as a time-dependent variable in these models in 
order that attribution of increased LOS to the presence of diarrhoea could be discerned from increased LOS as a 
risk factor for developing diarrhoea. As the proportional hazards assumption was violated for time to discharge, 
data was additionally split at each failure time and the analysis was stratified by time. A P-value of less than 0.05 
was considered statistically significant.
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